The government has committed to working with the organisation to establish “a sustainable funding and operating model” for the future, according to CPE chief executive Janet Morrison.
However, NPA stressed that the new funding deal still falls “a long way short of the NHS’s own estimates of the true cost of providing pharmacy services”.
The Department of Health and Social Care (DHSC) has proposed to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% in the second half of 2025.
